首頁 > 市場調查報告書 > 醫療設備

生技設備

細胞計數市場規模、佔有率及成長分析（按產品、應用、最終用戶及地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1902392

細胞計數市場規模、佔有率及成長分析（按產品、應用、最終用戶及地區分類）－2026-2033年產業預測

Cell Counting Market Size, Share, and Growth Analysis, By Product (Consumables, Instruments), By Application (Research Applications, Medical Applications), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 189 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，細胞計數市場規模將達到 111.8 億美元，到 2025 年將達到 119.4 億美元，到 2033 年將達到 202.1 億美元，預測期（2026-2033 年）的複合年成長率為 6.8%。

細胞計數市場正經歷顯著成長，這主要得益於細胞生物學、癌症研究和免疫學領域研究的不斷深入。推動該市場發展的關鍵因素包括對個人化醫療日益成長的需求、慢性病盛行率的急劇上升以及細胞計數技術的進步。然而，操作技術複雜性和訓練有素的專業人員短缺等挑戰可能會阻礙市場發展。儘管存在這些障礙，但由於創新技術的湧現、細胞療法日益重要以及數位化解決方案的整合，預計該市場仍將持續成長。因此，細胞計數領域將持續發展演進，反映其在各個領域，尤其是在改善醫學研究和診斷方面發揮的關鍵作用。

細胞計數市場促進因素

細胞計數市場的成長主要得益於技術創新，例如精密可靠的自動化細胞計數儀器、先進的流式細胞儀和高級成像系統的問世。這些發展推動了市場需求的成長，並刺激了市場擴張。現代細胞計數解決方案能夠提供快速、準確的結果和全面的分析，從而提高了效率和準確性，這也促進了市場成長。最終，這些技術進步在改善臨床診斷和提升研究成果方面發揮關鍵作用，進一步推動了市場發展，並凸顯了高效細胞計數方法在各個應用領域的重要性。

限制細胞計數市場發展的因素

在某些地區，各種細胞計數系統的報銷選擇有限，這給其經濟可行性帶來了挑戰，並可能阻礙醫療機構和研究人員採用該技術。這種限制會導致對細胞計數系統的需求下降，最終抑制市場擴張。此外，缺乏適當的報銷機制會抑制對創新細胞計數技術的投資，使相關人員難以探索或實施這些技術進步。因此，這些財務障礙顯著限制了細胞計數解決方案在醫療保健領域的潛在成長和整體應用。

細胞計數市場趨勢

細胞計數市場正經歷顯著的轉變，除了傳統的細胞計數技術外，人們也開始更加關注細胞功能和活力。研究人員和臨床醫生日益認知到，評估細胞數量固然重要，但評估細胞的健康狀況和活性同樣至關重要，這對於再生醫學、藥物研發和癌症研究等前沿應用至關重要。這一趨勢正在推動創新技術的開發，這些技術致力於全面評估細胞行為，最終有助於更深入地了解細胞機制。因此，對能夠更深入理解細胞活力和功能的先進工具和調查方法的需求預計將塑造該市場的未來模式。

消耗品
- 培養基、血清和試劑
- 檢測試劑盒
- 微孔盤
- 配件
- 其他消耗品
裝置
- 光強度
- 單模讀卡機
- 多模式閱讀器
- 流式細胞儀
- 血液分析儀
- 全自動分析儀
- 半自動血液分析儀
- 細胞計數器
- 自動細胞計數器
- 血球計數器/手動細胞計數器
- 顯微鏡

按應用分類的細胞計數市場

研究用途
- 癌症研究
- 免疫學研究
- 神經學檢查
- 幹細胞研究
- 其他研究應用
醫療用途
- 非侵入性產前檢測
- 體外受精
- 循環性腫瘤細胞檢測
工業應用

按最終用戶分類的細胞計數市場

研究所
醫院和診斷檢查室
製藥和生物技術公司以及受託研究機構（CRO）
其他最終用戶

按地區分類的細胞計數市場規模

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲（MEA）
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭格局

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市集活動
主要企業市佔率（2025 年）

主要企業簡介

Danaher Corporation（US）
Thermo Fisher Scientific（US）
Becton, Dickinson and Company（US）
Merck KGaA（Germany）
Bio-Rad Laboratories Inc.（US）
Abbott Laboratories（US）
PerkinElmer, Inc.（US）
Agilent Technologies, Inc.（US）
Corning（US）
Tecan（Switzerland）
Boule Diagnostics AB（Sweden）
Olympus Corporation（Japan）
Horiba（Japan）
Sysmex Corporation（Japan）
Siemens Healthineers AG（Germany）
F. Hoffmann-La Roche AG（Switzerland）
Luminex Corporation（US）
Nexcelom Bioscience LLC（US）
Tip Biosystems（Singapore）
Logos Biosystems, Inc.（South Korea）

簡介目錄

Product Code: SQMIG35H2305

Cell Counting Market size was valued at USD 11.18 Billion in 2024 and is poised to grow from USD 11.94 Billion in 2025 to USD 20.21 Billion by 2033, growing at a CAGR of 6.8% during the forecast period (2026-2033).

The cell counting market is witnessing significant growth driven by an increase in research across cell biology, cancer research, and immunology. Key factors propelling this market include the rising demand for personalized medicine, a surge in chronic disease prevalence, and advancements in cell counting technologies. However, challenges such as operational technical complexity and a shortage of trained professionals may hinder progress. Despite these obstacles, the market is anticipated to thrive, fueled by the advent of innovative technologies, the escalating importance of cell-based therapies, and the integration of digital solutions. Consequently, the landscape for cell counting is set for continuous evolution, reflecting its critical role in various fields, particularly in enhancing medical research and diagnostics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cell Counting market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cell Counting Market Segments Analysis

Global Cell Counting Market is segmented by Product, Application, End User, and region. Based on Product, the market is segmented into Consumables, and Instruments. Based on Application, the market is segmented into Research Applications, Medical Applications, and Industrial Applications. Based on End User, the market is segmented into Research Institutes, Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies and Contract Research Organizations (CROS), and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Cell Counting Market

The growth of the cell counting market is significantly driven by substantial innovations in technology, including the introduction of sophisticated and reliable automated cell counters, cutting-edge flow cytometers, and advanced imaging systems. These developments are fostering increased demand and stimulating market expansion. The heightened efficiency and precision of modern cell counting solutions are also contributing to this growth, as they provide rapid and accurate results alongside comprehensive analyses. Ultimately, these technological advancements play a crucial role in enhancing clinical diagnostics and bolstering research outcomes, thereby further motivating market progression and establishing the importance of effective cell counting methods in various applications.

Restraints in the Cell Counting Market

In certain areas, the limited reimbursement options available for various cell counting systems can pose challenges to their financial viability, hindering the willingness of healthcare providers and researchers to adopt these technologies. This constraint may lead to reduced demand for cell counting systems, ultimately stifling market expansion. Additionally, the absence of adequate reimbursement mechanisms can discourage investment in innovative cell counting technologies, making it difficult for stakeholders to explore or implement these advancements. Consequently, these financial barriers significantly limit the potential growth and overall adoption of cell counting solutions within the healthcare sector.

Market Trends of the Cell Counting Market

The Cell Counting market is experiencing a notable shift towards prioritizing cell functionality and viability alongside traditional cell counting methods. Researchers and clinicians are increasingly recognizing the importance of assessing not just the quantity of cells but also their health and activity, vital for advanced applications in regenerative medicine, drug discovery, and cancer research. This trend is driving the development of innovative technologies tailored for comprehensive evaluations of cell behavior, ultimately yielding deeper insights into cellular mechanisms. As a result, the demand for sophisticated tools and methodologies that enhance understanding of cell viability and function is set to shape the future landscape of this market.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Regulatory Analysis
Value Chain Analysis
Case Study Analysis

Cell Counting Market by Product

Market Overview
Consumables
- Media, Sera, And Reagents
- Assay Kits
- Microplates
- Accessories
- Other Consumables
Instruments
- Spectrophotometers
- Single-Mode Readers
- Multi-Mode Readers
- Flow Cytometers
- Hematology Analyzers
- Fully Automated Analyzers
- Semi-Automated Hematology Analyzers
- Cell Counters
- Automated Cell Counters
- Hemocytometers/Manual Cell Counters
- Microscopes

Cell Counting Market by Application

Market Overview
Research Applications
- Cancer Research
- Immunology Research
- Neurology Research
- Stem Cell Research
- Other Research Applications
Medical Applications
- Noninvasive Prenatal Diagnosis
- In Vitro Fertilization
- Circulating Tumor Cell Detection
Industrial Applications

Cell Counting Market by End User

Market Overview
Research Institutes
Hospitals & Diagnostic Laboratories
Pharmaceutical & Biotechnology Companies and Contract Research Organizations (CROS)
Other End Users

Cell Counting Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2025

Key Company Profiles

Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Corning (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tecan (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boule Diagnostics AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Horiba (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Luminex Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nexcelom Bioscience LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tip Biosystems (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Logos Biosystems, Inc. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments